Growth Metrics

Moderna (MRNA) Change in Taxes (2021 - 2024)

Moderna (MRNA) has disclosed Change in Taxes for 4 consecutive years, with -$2.0 million as the latest value for Q3 2024.

  • For Q3 2024, Change in Taxes fell 122.22% year-over-year to -$2.0 million; the TTM value through Sep 2024 reached -$51.0 million, down 410.0%, while the annual FY2023 figure was $15.0 million, 101.81% up from the prior year.
  • Change in Taxes hit -$2.0 million in Q3 2024 for Moderna, up from -$45.0 million in the prior quarter.
  • Across five years, Change in Taxes topped out at $716.0 million in Q1 2022 and bottomed at -$1.2 billion in Q2 2022.
  • Average Change in Taxes over 4 years is $333333.3, with a median of $7.0 million recorded in 2023.
  • On a YoY basis, Change in Taxes climbed as much as 695.56% in 2022 and fell as far as 533.1% in 2022.
  • Moderna's Change in Taxes stood at $311.0 million in 2021, then tumbled by 105.79% to -$18.0 million in 2022, then surged by 138.89% to $7.0 million in 2023, then crashed by 128.57% to -$2.0 million in 2024.
  • According to Business Quant data, Change in Taxes over the past three periods came in at -$2.0 million, -$45.0 million, and -$11.0 million for Q3 2024, Q2 2024, and Q1 2024 respectively.